Form 8-K XPLR Infrastructure, LP For: Jul 28 Jul 28, 2026 07:35AM false000160314500016031452026-07-282026-07-28UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934Date of earliest event reported:  July 28, 2026CommissionFileNumberExact name of registrant as specified in itscharter, address of principal executive offices andregistrant's telephone numberIRS EmployerIdentificationNumber1-36518XPLR INFRASTRUCTURE, LP30-0818558700... (continue reading...)
Form 424B3 KAZIA THERAPEUTICS LTD Jul 28, 2026 07:34AM

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-284606

 

PROSPECTUS SUPPLEMENT

(to Prospectus dated December 22, 2025)

 

266,666 American Depositary Shares representing

133,333,000

Ordinary Shares

 

 

Kazia Therapeutics Limited

  

This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated December 22, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form... (continue reading...)


Form 8-K Kiniksa Pharmaceuticals For: Jul 28 Jul 28, 2026 07:34AM 0001730430false00017304302026-07-282026-07-28

​

​

UNITED STATESSECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

​

FORM 8-K

​

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported): July 28, 2026

​

Kiniksa Pharmaceuticals International, plc

(Exact name of Registrant as Specified in Its Charter)

​

​

​

​

​

​

England and Wales

  ​ ​ ​

001-730430

  ​ ​ ​

98-1795578

(State or other jurisdiction ofincorporation... (continue reading...)


Form 424B3 KAZIA THERAPEUTICS LTD Jul 28, 2026 07:34AM

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-290598

 

PROSPECTUS SUPPLEMENT

(to Prospectus dated December 23, 2025)

 

232,956 American Depositary Shares representing

116,478,000

Ordinary Shares

 

 

 

Kazia Therapeutics Limited

  

This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated December 23, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form... (continue reading...)


Form 424B3 KAZIA THERAPEUTICS LTD Jul 28, 2026 07:32AM

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-276774

PROSPECTUS SUPPLEMENT

(to Prospectus dated December 22, 2025)

 

95,110 American Depositary Shares representing

47,555,000

Ordinary Shares

 

 

Kazia Therapeutics Limited

  

This prospectus supplement is being filed to update and supplement the information contained in the prospectus dated December 22, 2025 (the “Prospectus”), which forms a part of our Registration Statement on Form F-1... (continue reading...)


More SEC Filings

View Older Stories

Jul 28, 2026 07:32AM Form 8-K CONAGRA BRANDS INC. For: Jul 24
Jul 28, 2026 07:31AM Form 424B3 KAZIA THERAPEUTICS LTD
Jul 28, 2026 07:31AM Form 8-K BOEING CO For: Jul 28
Jul 28, 2026 07:30AM Form 6-K KAZIA THERAPEUTICS LTD For: Jul 28
Jul 28, 2026 07:30AM Form 10-Q Orbit Innovations Group For: Jun 30
Jul 28, 2026 07:28AM Form 424B4 Catalyst Acquisition
Jul 28, 2026 07:25AM Form 6-K Amber International Hold For: Jul 28
Jul 28, 2026 07:24AM Form MA-I GOLDMAN SACHS & CO. LLC
Jul 28, 2026 07:24AM Form MA-I/A D.A. DAVIDSON & CO.
Jul 28, 2026 07:24AM Form MA-I/A D.A. DAVIDSON & CO.
Jul 28, 2026 07:20AM Form 6-K Galmed Pharmaceuticals For: Jul 28
Jul 28, 2026 07:16AM Form 8-K Grace Therapeutics, Inc. For: Jul 28
Jul 28, 2026 07:14AM Form 8-K REPLIGEN CORP For: Jul 28
Jul 28, 2026 07:11AM Form D Vitalbridge Fund III,
Jul 28, 2026 07:10AM Form 8-K S&P Global Inc. For: Jul 28
Jul 28, 2026 07:09AM Form 10-Q Core Scientific, Inc./tx For: Jun 30
Jul 28, 2026 07:07AM Form 6-K Lifezone Metals Ltd For: Jul 28
Jul 28, 2026 07:06AM Form 8-K Xylem Inc. For: Jul 28
Jul 28, 2026 07:06AM Form 8-K Core Scientific, Inc./tx For: Jul 28
Jul 28, 2026 07:06AM Form 8-K SHERWIN WILLIAMS CO For: Jul 28
Jul 28, 2026 07:05AM Form 8-K AMERICAN TOWER CORP /MA/ For: Jul 28
Jul 28, 2026 07:05AM Form 8-K Alkermes plc. For: Jul 28
Jul 28, 2026 07:05AM Form 13F-HR OP Asset Management Ltd For: Jun 30
Jul 28, 2026 07:05AM Form 6-K DoubleDown Interactive For: Jul 28
Jul 28, 2026 07:05AM Form 6-K RedHill Biopharma Ltd. For: Jul 28
Jul 28, 2026 07:04AM Form 8-K Altimmune, Inc. For: Jul 28
Jul 28, 2026 07:04AM Form 8-K ASBURY AUTOMOTIVE GROUP For: Jul 28
Jul 28, 2026 07:04AM Form 8-K JETBLUE AIRWAYS CORP For: Jul 28
Jul 28, 2026 07:03AM Form 10-Q JETBLUE AIRWAYS CORP For: Jun 30
Jul 28, 2026 07:03AM Form 8-K IQVIA HOLDINGS INC. For: Jul 28
Jul 28, 2026 07:03AM Form 8-K CORNING INC /NY For: Jul 28
Jul 28, 2026 07:03AM Form 8-K PayPal Holdings, Inc. For: Jul 28
Jul 28, 2026 07:02AM Form 8-K INCYTE CORP For: Jul 28
Jul 28, 2026 07:02AM Form 13F-HR Wesleyan Assurance Socie For: Jun 30
Jul 28, 2026 07:02AM Form 6-K VersaBank For: Jul 28
Jul 28, 2026 07:01AM Form 8-K ConnectOne Bancorp, Inc. For: Jul 28
Jul 28, 2026 07:01AM Form 10-Q ARMSTRONG WORLD INDUSTRI For: Jun 30
Jul 28, 2026 07:01AM Form 8-K Core Scientific, Inc./tx For: Jul 27
Jul 28, 2026 07:01AM Form 8-K REDWOOD TRUST INC For: Jul 28
Jul 28, 2026 07:00AM Form 8-K HORMEL FOODS CORP /DE/ For: Jul 27
Jul 28, 2026 07:00AM Form 6-K OKYO Pharma Ltd For: Jul 28
Jul 28, 2026 07:00AM Form 6-K SNDL Inc. For: Jul 28
Jul 28, 2026 06:59AM Form 8-K Invesco Ltd. For: Jul 28
Jul 28, 2026 06:58AM Form 8-K CARRIER GLOBAL Corp For: Jul 28
Jul 28, 2026 06:58AM Form 8-K COCA COLA CO For: Jul 28
Jul 28, 2026 06:56AM Form 8-K RLI CORP For: Jul 23
Jul 28, 2026 06:55AM Form 6-K Vista Energy, S.A.B. de For: Jul 28
Jul 28, 2026 06:54AM Form 8-K PENTAIR plc For: Jul 28
Jul 28, 2026 06:50AM Form MA/A STIFEL, NICOLAUS & COMPA
Jul 28, 2026 06:50AM Form 8-K PJT Partners Inc. For: Jul 28
View Older Stories